Having trouble accessing articles? Reset your cache.

Limb-girdle muscular dystrophy gene therapy data lift Sarepta

Early data from a Phase I/II study of SRP-9003 to treat a form of limb-girdle muscular dystrophy showed the gene therapy led to functional improvements in all three patients in a low-dose cohort at nine months. Results from a planned higher-dose cohort would inform the design of a pivotal study;

Read the full word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers